Titre :
  • Risk of acute myeloid leukemia and myelodysplastic syndrome in trials of adjuvant epirubicin for early breast cancer: correlation with doses of epirubicin and cyclophosphamide.
Auteur : Praga, Claudio ; Bergh, Jonas ; Bliss, Judith ; Bonneterre, J ; Cesana, Bruno ; Coombes, R Charles ; Fargeot, Pierre ; Folin, Annika ; Fumoleau, Pierre ; Giuliani, Rosa ; Kerbrat, Pierre ; Hery, Michel ; Nilsson, Jonas ; Onida, Francesco ; Piccart-Gebhart, Martine ; Shepherd, L ; Therasse, P. ; Wils, J ; Rogers, David
Informations sur la publication : Journal of clinical oncology, 23, 18, (page 4179-4191)
Statut de publication : Publié, 2005-06
Sujet CREF : Sciences bio-médicales et agricoles
Mots-clés MeSH : Adult
Antineoplastic Combined Chemotherapy Protocols -- adverse effects
Breast Neoplasms -- drug therapy
Chemotherapy, Adjuvant -- adverse effects
Cyclophosphamide -- adverse effects
Cyclophosphamide -- therapeutic use
Data Interpretation, Statistical
Epirubicin -- adverse effects
Epirubicin -- therapeutic use
Female
Follow-Up Studies
Humans
Leukemia, Myeloid, Acute -- chemically induced
Middle Aged
Myelodysplastic Syndromes -- chemically induced
Randomized Controlled Trials as Topic
Risk Factors
Note : Journal Article
Research Support, Non-U.S. Gov't
Langue :
  • Anglais
Identificateurs : urn:issn:0732-183X 
info:doi/10.1200/JCO.2005.05.029
info:pii/23/18/4179
info:pmid/15961765